Headlands Research’s Post

https://lnkd.in/ddHb8npm We will be attending the Alzheimer's Association® International Conference (AAIC) in Philadelphia from July 28th to August 1st! We'll have Brittany Weddington, Director of Business Development; Dani Cabral, MD, Principal Investigator of our Phoenix site; Mireya Medina, Site Director of our Albuquerque site there to discuss the latest research and learn more about our work in Alzheimer's disease. Set up a meeting today! #AAIC2024 #AlzheimersResearch #DementiaResearch #ClinicalTrials #AlzheimersandBrainAwarenessMonth

By 2050, experts expect the number of people living with Alzheimer's Disease will triple. As a clinical research network, our sites across the country work every day to ensure successful clinical trials in #Alz research for everyone. Join us in honoring #WorldAlzheimersDay today by wearing purple and sharing information on our clinical trial opportunities. It is #NeverTooLate to get involved! To learn more about our centers of excellence dedicated to ending Alzheimer's Disease, visit cenexel.com. #WorldAlzheimersDay2023 #EndAlz #AlzheimersResearch #ClinicalResearch #ClinicalTrials #CenExel

We were delighted to introduce InRAD, an international, practice-based registry for Alzheimer's Disease and other dementias at the EADC (European Alzheimer's Disease Consortium) annual meeting yesterday.   One of our founding Board members, Frank Jessen, explained how InRAD can help address pressing questions about the clinical management of Alzheimer's disease, enable large study collaborations with a common minimum data set and facilitate a wide range of sub-studies on a global scale.   Click here to find out more about InRAD and join our effort to accelerate progress in Alzheimer's practice-based research: https://lnkd.in/gGDTvs6i   #InRAD #AlzheimersResearch #GlobalImpact #EADC #RealWorldData #AlzheimersRegistry

Registries are powerful tools for conducting observational studies of disease with impact on public health surveillance, research, and intervention, and inform and engage policymakers. Frank Jessen, one of our founding Board members, shared at the EADC (European Alzheimer's Disease Consortium) annual meeting how InRAD may impact clinical management, foster large-scale collaborations, and enable global studies. Join us in accelerating Alzheimer's research!  https://lnkd.in/gGDTvs6i  #InRAD #AlzheimersResearch #GlobalImpact #EADC #RealWorldData #AlzheimersRegistry

Today, on 𝐖𝐨𝐫𝐥𝐝 𝐀𝐥𝐳𝐡𝐞𝐢𝐦𝐞𝐫'𝐬 𝐃𝐚𝐲, we stand together to raise awareness, foster understanding, and support those affected by Alzheimer's disease. There are over 55 million people living with Alzheimer’s disease or other dementias in the world today. We understand how much Alzheimer's affects people and their families and we're dedicated to advancing medical research in this important area. We invite you to join us in making a brighter future. Together, we can make a difference in the fight against Alzheimer's disease. Let's raise awareness, and continue our commitment to advancing research and finding a cure.  𝐖𝐨𝐫𝐥𝐝 𝐀𝐥𝐳𝐡𝐞𝐢𝐦𝐞𝐫'𝐬 𝐃𝐚𝐲 - "𝐍𝐞𝐯𝐞𝐫 𝐭𝐨𝐨 𝐞𝐚𝐫𝐥𝐲, 𝐧𝐞𝐯𝐞𝐫 𝐭𝐨𝐨 𝐥𝐚𝐭𝐞” #WorldAlzheimersDay #alzheimersdisease #nevertoolatenevertooearly

#Alzheimers has a devastating impact on the lives of the affected and their families. While there is no cure for Alzheimer's at the moment, funding research initiatives is imperative to learn everything about the disease, come up with appropriate treatments, and finally find a cure. This #WorldAlzheimersDay2023, let’s hope that more research projects are funded to find an effective treatment for the deadly disease. #AlzheimersDay #InternationalAlzheimersDay #ClinicalTrials 

📢 Exciting News! AriBio is thrilled to announce our participation at CTAD (Clinical Trials on Alzheimer's Disease) next week. This crucial gathering brings industry pioneers and academic leaders together to accelerate the development of effective treatments against Alzheimer's Disease. We are eager to collaborate, learn, and contribute to the fight against Alzheimer's. Stay tuned for updates on our insights and progress at CTAD! 🧠💡 Comment if you are attending! #CTAD23 #AlzheimersResearch #CTADconference

Join us this September as we observe #WorldAlzheimersMonth 🌎 This is a global initiative to challenge the misconceptions around Alzheimer's and dementia. Let's use this time to advocate, discuss and share resources 🗣️📚 Enlighten ourselves and others about the disease's impact. Remember, knowledge is power - the more we understand, the closer we get to finding a cure 💡💪 Stay tuned for various events and campaigns throughout this month. These are aimed at educating, supporting, and accelerating progress in Alzheimer's research 📅🔬 #EndAlz #AlzheimersAwareness #DementiaAwareness #KnowledgeIsPower #FindACure

If you’re at CTAD 2023, join us during breaks to discover how ALZ-801 is advancing in the fight against Alzheimer's. 🧠 Together, we can make a difference! #Alzheimers #CTAD23 CTAD Clinical Trials on Alzheimer's Disease

"Excited to unveil my research at SENDCon 2023! Investigating the early stages of Alzheimer's with a focus on APP cleavage by AEP. Join me in the quest for a deeper understanding of this devastating disease and its potential treatment. Together, we can make a difference. I am sincerely grateful to Dr. Rajesh Amin for his invaluable guidance during the study. #SENDCon2023 #AlzheimersResearch #ScienceForACause"